Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases

Introduction: Childhood acute lymphoblastic leukemia (ALL) is a hematologic malignancy characterized by the acquisition of several genetic lesions in the lymphoid progenitors with subsequent proliferation advantage and lack of maturation. Along the years, it has been repeatedly shown that minimal re...

詳細記述

保存先:
書誌詳細
出版年:Front Oncol
主要な著者: Radu, Letitia-Elena, Colita, Andrei, Pasca, Sergiu, Tomuleasa, Ciprian, Popa, Codruta, Serban, Catalin, Gheorghe, Anca, Serbanica, Andreea, Jercan, Cristina, Marcu, Andra, Bica, Ana, Teodorescu, Patric, Constantinescu, Catalin, Petrushev, Bobe, Asan, Minodora, Jardan, Cerasela, Dragomir, Mihaela, Tanase, Alina, Colita, Anca
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2020
主題:
Oncology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7338564/
https://ncbi.nlm.nih.gov/pubmed/32695667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00923
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料